# An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

> **NCT01200225** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 1155 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01200225
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 1155 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01200225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01200225, "An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01200225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*